Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stina Lindman

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2007
Nucleation of protein fibrillation by nanoparticlesSara Linse, Celia Cabaleiro-Lago, Wei-Feng Xue, et al.
Journal of the American Chemical Society|October 29, 2008
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticlesCelia Cabaleiro-Lago, Fiona Quinlan-Pluck, Iseult Lynch, et al.
Protein Engineering, Design & Selection : PEDS|December 5, 2009
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodiesErika Gustafsson, Anna Rosén, Karin Barchan, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2007
Nucleation of protein fibrillation by nanoparticlesSara Linse, Celia Cabaleiro-Lago, Wei-Feng Xue, et al.
Journal of the American Chemical Society|October 29, 2008
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticlesCelia Cabaleiro-Lago, Fiona Quinlan-Pluck, Iseult Lynch, et al.
Protein Engineering, Design & Selection : PEDS|December 5, 2009
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodiesErika Gustafsson, Anna Rosén, Karin Barchan, et al.
Pageof 2